Diagnostic chain Metropolis Healthcare Ltd is considering an initial public offering.
According to a Bloomberg report, the company plans to raise Rs 1,500 crore through an IPO to fund acquisitions. Part of the funds raised would also be used to buy out Carlyle's stake in Metropolis, the report added. The Carlyle group had picked up stake in Metropolis in 2015 for an undisclosed sum.
The company's promoter and Managing Director, Ameera Shah, told Bloomberg that the share sale would be a combination of promoters shares and new shares.
In expansion mode
Earlier this year, Metropolis had said it plans to add 800 collection centres and around 10 laboratories by the end of FY19. The company currently has 150 labs with 1,800 collection centres. It is also looking to grow its presence in the northern and eastern markets.
Indian diagnostics industry is highly fragmented with nearly half the market share held by standalone players. The The listed companies in this segment include Dr Lal Pathlabs and Thyrocare Technologies.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.